Skip to main content
    C

    Century Therapeutics Inc (IPSC)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $1.64
    -0.01 (-0.61%)

    Market Cap: $299.63M

    Last updated: Nov 17, 2026 at 11:06 AM ET

    Century Therapeutics Inc (IPSC) Earnings: Report Dates and Results

    Updated Nov 12, 2026. Results come from company earnings reports, and estimates are consensus analyst estimates.

    Century Therapeutics (IPSC) is expected to report earnings on Mar 10, 2027. In the quarter ended Sep 30, 2026, Century Therapeutics reported EPS of -$0.11, above the -$0.12 estimate. It beat the EPS estimate in 6 of the last 8 quarters.

    Earnings

    Performance (10Y)

    Beat Rate
    52%(12/23)
    Avg Surprise
    -28.56%
    Streak
    1 Q

    Upcoming Estimates

    Reports Mar 10, 2027 (est.)Period ending Dec 31, 2026
    EPS Consensus-$0.13
    Range-$0.14 - -$0.13
    8 analysts
    Revenue Consensus
    N/A
    RangeN/A
    8 analysts

    Next Report

    IPSC has an expected report date of Mar 10, 2027.

    Earnings History

    Of the 23 quarters below that had an estimate, IPSC beat 12, missed 10 and matched 1. The widest gap in the table came in the quarter ended Mar 31, 2021, when EPS landed 443.18% below the estimate.

    Quarter endedEPSEstimateRangeSurpriseResultYoYAnalystsRevisionsReportedRevenue
    Sep 30, 2026-$0.11-$0.12-$0.12 - -$0.08+8.33%BeatN/A41 up, 1 downNov 12, 2026N/A
    Jun 30, 2026-$0.17-$0.11-$0.13 - -$0.11-54.55%MissN/A32 up, 0 downAug 12, 2026N/A
    Mar 31, 2026-$0.11-$0.17-$0.22 - -$0.13+35.29%Beat-112.4%20 up, 0 downMay 13, 2026N/A
    Dec 31, 2025-$0.25-$0.30-$0.36 - -$0.24+15.97%BeatN/A22 up, 0 downMar 12, 2026N/A
    Sep 30, 2025-$0.32-$0.38-$0.39 - -$0.38+15.79%BeatN/A21 up, 1 downNov 13, 2025N/A
    Jun 30, 2025-$0.38-$0.37-$0.40 - -$0.35-2.70%MissN/A20 up, 0 downAug 14, 2025N/A
    Mar 31, 2025$0.89-$0.31-$0.44 - $0.79+387.10%BeatN/A21 up, 0 downMay 15, 2025$109.16M
    Dec 31, 2024-$0.43-$0.45-$0.47 - -$0.41+4.44%BeatN/A43 up, 0 downMar 19, 2025$4.17M
    Sep 30, 2024-$0.37-$0.45-$0.51 - -$0.41+17.78%BeatN/A50 up, 0 downNov 5, 2024$791000
    Jun 30, 2024-$0.38-$0.50-$0.61 - -$0.37+24.00%BeatN/A50 up, 0 downAug 8, 2024$771000
    Mar 31, 2024-$0.45-$0.45-$0.56 - -$0.440.00%In lineN/A60 up, 0 downMay 9, 2024$855000
    Dec 31, 2023-$0.65-$0.55-$0.70 - -$0.40-18.18%MissN/A71 up, 0 downMar 14, 2024$268000
    Sep 30, 2023-$0.55-$0.49-$0.58 - -$0.45-12.24%MissN/A70 up, 0 downNov 9, 2023$148000
    Jun 30, 2023-$0.49-$0.54-$0.59 - -$0.49+9.26%BeatN/A80 up, 0 downAug 9, 2023$99000
    Mar 31, 2023-$0.53-$0.52-$0.58 - -$0.44-1.92%MissN/A90 up, 0 downMay 11, 2023$1.72M
    Dec 31, 2022-$2.27-$0.59N/A-284.75%MissN/AN/A0 up, 0 downMar 16, 2023$521000
    Sep 30, 2022-$0.53-$0.60-$0.67 - -$0.52+11.67%BeatN/A90 up, 0 downNov 10, 2022$2.22M
    Jun 30, 2022-$0.54-$0.50-$0.61 - -$0.48-8.00%MissN/A70 up, 0 downAug 11, 2022$1.40M
    Mar 31, 2022-$0.48-$0.54-$0.57 - -$0.19+11.11%BeatN/A40 up, 0 downMay 16, 2022$1.06M
    Dec 31, 2021-$0.24-$0.48-$0.50 - -$0.43+50.00%BeatN/A4N/AMar 17, 2022N/A
    Sep 30, 2021-$0.48-$0.42-$0.43 - -$0.36-14.29%MissN/A40 up, 0 downNov 10, 2021N/A
    Jun 30, 2021-$1.93-$0.38N/A-407.89%MissN/A3N/AAug 12, 2021N/A
    Mar 31, 2021-$2.39-$0.44N/A-443.18%MissN/AN/AN/AJun 21, 2021N/A
    Dec 31, 2020-$0.95N/AN/AN/AN/AN/AN/AN/AMar 30, 2021N/A
    Dec 31, 2019-$0.51N/AN/AN/AN/AN/AN/AN/AMar 30, 2020N/A
    Last 25 quarters

    Annual EPS

    EPS for the fiscal year ended Dec 31, 2025 was -$0.06, after -$1.63 the year before. It was -$0.51 for the year ended Dec 31, 2019, the oldest of the 7 fiscal years shown.

    Fiscal year endedEPSChange
    Dec 31, 2025-$0.06N/A
    Dec 31, 2024-$1.63N/A
    Dec 31, 2023-$2.22N/A
    Dec 31, 2022-$3.82N/A
    Dec 31, 2021-$5.04N/A
    Dec 31, 2020-$0.95N/A
    Dec 31, 2019-$0.51N/A

    Frequently Asked Questions About IPSC

    When is Century Therapeutics's next earnings date?

    Century Therapeutics's next earnings report is expected for Mar 10, 2027.

    Did IPSC beat earnings estimates last quarter?

    Yes. Century Therapeutics reported EPS of -$0.11 for the quarter ended Sep 30, 2026, above the -$0.12 estimate, a 8.33% surprise.

    What EPS do analysts expect from IPSC next quarter?

    The consensus EPS estimate for Century Therapeutics for the quarter ending Dec 31, 2026 is -$0.13 from 8 analysts, with estimates from -$0.14 to -$0.13.

    How often does IPSC beat earnings estimates?

    Century Therapeutics beat the EPS estimate in 6 of the last 8 quarters, with an average surprise of +51.21%.